HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hugo C Castro Faria Neto Selected Research

LASSBio-468

3/2005LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hugo C Castro Faria Neto Research Topics

Disease

2Inflammation (Inflammations)
03/2005 - 03/2005
1Ischemic Stroke
09/2013
1Stroke (Strokes)
09/2013
1Dementia (Dementias)
09/2013
1Glioblastoma (Glioblastoma Multiforme)
09/2013
1Glioma (Gliomas)
09/2013
1Infections
09/2013
1Malaria
09/2013
1Neoplasms (Cancer)
09/2013
1Septic Shock (Toxic Shock Syndrome)
09/2013
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2013
1Pneumonia (Pneumonitis)
10/2011
1Thrombosis (Thrombus)
10/2011
1Shock
03/2005
1Sepsis (Septicemia)
03/2005
1Arthritis (Polyarthritis)
03/2005

Drug/Important Bio-Agent (IBA)

2CytokinesIBA
03/2005 - 03/2005
1phenyl-N-tert-butylnitroneIBA
09/2013
1disufenton sodium (NXY 059)IBA
09/2013
1OKN 007IBA
09/2013
1nitronesIBA
09/2013
1Biological ProductsIBA
09/2013
1EstersIBA
09/2013
1KetamineFDA LinkGeneric
09/2013
1lanthionineIBA
09/2013
1AntithrombinsIBA
10/2011
1fibrin fragment D (D-dimer)IBA
10/2011
1EnzymesIBA
03/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2005
1Thalidomide (Thalomid)FDA Link
03/2005
1LASSBio-468IBA
03/2005
1Platelet Activating FactorIBA
03/2005
1Biomarkers (Surrogate Marker)IBA
03/2005

Therapy/Procedure

1Therapeutics
09/2013